期刊文献+

颈动脉支架置入后支架内再狭窄 被引量:6

In-stent restenosis after carotid stenting
原文传递
导出
摘要 颈动脉支架置入术已成为颈动脉狭窄的有效治疗方法之一。支架内再狭窄是影响颈动脉支架置入术远期效果的主要原因之一,也是影响患者预后的重要因素。支架内再狭窄的监测、预防和治疗始终是临床上的一大难题。文章就近年来支架内再狭窄的相关研究进展做了综述。 Carotid stenting has become one of the effective ways in the treatment of carotid artery stenosis. In-stent restenosis is one of the major causes impacting long-term effects following carotid stenting. It is also an important factor for impacting the prognosis of patients. The monitoring, prevention and treatment of in-stent restenosis have been a major clinical chanllege. This article reviews the progress in research on the in-stent restenosis in recent years.
作者 闫冠华 王雁
出处 《国际脑血管病杂志》 北大核心 2011年第9期714-718,共5页 International Journal of Cerebrovascular Diseases
关键词 颈动脉狭窄 颈动脉支架置入术 支架内再狭窄 Carotid stenosis Stents Recurrence Stroke
  • 相关文献

参考文献1

二级参考文献25

  • 1Hoffmann, LR., Mintz, G.S., Dussaillant, G.R., Popma, J.J., Pichard, A.D., Satler, L.F., Kent, K.M., Griffin, J., Leon, M.B., 1996. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation, 94(6): 1247-1254. 被引量:1
  • 2Holmes, D.R.Jr., Teirstein, P., Satler, L., Sketch, M., O'Malley J., Popma, J.J., Kuntz, R.E., Fitzgerald, P.J., Wang, H., Caramanica, E., et al., 2006. Sirolimus-eluting stents vs. vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. The Journal of the American Medical Association, 295(11):1264- 1273. [doi:10.1001/jama.295.11.1264]. 被引量:1
  • 3Kastrati, A., Mehilli, J., Dirschinger, J., Pache, J., Ulm, K., Schtihlen, H., Seyfarth, M., Schmitt, C., Blasini, R., Neumann, F.J., et al., 2001. Restenosis after coronary placement of various stent types. The American Journal of Cardiology, 87(1):34-39. [doi:10.1016/S0002-9149(00) 01268-6]. 被引量:1
  • 4Kastrati, A., Mehilli, J., von Beckerath, N., Dibra, A., Hausleiter, J., Pache, J., Schuhlen, H., Schmitt, C., Dirschinger, J., Schomig, A., et al., 2005a. Sirolimus-eluting stent or paclitaxel-eluting stent vs. balloon angioplasty for prevention of recurrence in patient with coronary in-stent restenosis: a randomized controlled trial (ISAR-DESIRE) The Journal of the American Medical Association, 293(2) 165-171. [doi:10.1001/jama.293.2.165]. 被引量:1
  • 5Kastrati, A., Dibra, A., Eberle, S., Mehilli, J., Suarez de Lezo, J., Goy, J.J., Ulm, K., Schomig, A., 2005b. Sirolimuseluting stents vs. paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. The Journal of the American Medical Association, 294(7):819-825. [doi:10.1001/jama.294.7.819]. 被引量:1
  • 6Komowski, R., Hong, M.K., Tio, F.O., Bramwell, O., Wu, H., Leon, M.B., 1998. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. Journal of the American College of Cardiology, 31(1):224-230. [doi: 10.1016/S0735-1097(97)00450-6]. 被引量:1
  • 7Liistro, F., Fineschi, M., Angioli, P., Sinicropi, G., Falsini, G., Gori, T., Ducci, K., Bravi, A., Bolognese, L., 2006. Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: the TRUE (Tuscany registry of sirolimus for unselected in-stent restenosis) Registry. Journal of the American College of Cardiology, 48(2): 270-275. [doi: 10.1016/j.jacc.2006.03.039]. 被引量:1
  • 8Mehran, R., Dangas, G., Abizaid, A.S., Mintz, G.S., Lansky, A.J., Satler, L.F., Pichard, A.D., Kent, K.M., Stone, G.W., Leon, M.B., 1999. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation, 100(18): 1872-1878. 被引量:1
  • 9Moses, J.W., Leon, M.B., Popma, J.J., Fitzgerald, P.J., Holmes D.R., O'Shaughnessy, C., Caputo, R.P., Kereiakes, D.J., Williams, D.O., Teirstein, P.S., et al., 2003. Sirolimuseluting stents versus standard stents in patients with stenosis in a native coronary artery. The New England Journal of Medicine, 349(14):1315-1323. [doi:10.1056/ NEJMoa035071]. 被引量:1
  • 10Neumann, F.J., Desmet, W., Grube, E., Brachmann, J., Presbitero, P., Rubartelli, P., Mugge, A., Di Pede, F., Fullgraf, D., Aengevaeren, W., et al., 2005. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation, 111(16):2107-2111. [doi:10.1161/01 .CIR.0000162467.53 001.6B]. 被引量:1

共引文献2

同被引文献47

  • 1王桂红,姜卫剑,王拥军.脑高灌注综合征的研究进展[J].中国卒中杂志,2006,1(5):378-382. 被引量:26
  • 2徐格林,樊新颖,殷勤,张仁良,刘新峰.颈动脉支架置入术后发生持续性低血压的危险因素分析[J].中国脑血管病杂志,2007,4(5):218-222. 被引量:29
  • 3Eskandari MK,Usman AA,Garcia-Toca M, et al. Eight-yearinstitutional review of carotid artery stenting [J]. J Vase Surg,2010,51(5) :1145-1151. 被引量:1
  • 4Saito T, Hokimoto S, Oshima S, et al. Metal allergic reaction inchronic refractory in-stent restenosis [ J ]. Cardiovasc Revasc Med,2009,10(1) :17-22. 被引量:1
  • 5Mohler ER 3rd Carotid stenting for atherothrombosis.Heart,2007,93(3):1147-1151. 被引量:1
  • 6Bergeron P,Roux M,Khanoyan P,et al.Long-term.results of carotid stending are competitive.With surgery.Vasc surg,2005,41 (2):213. 被引量:1
  • 7Chakthtoura EY,Hobson RW 2nd,Goldstein J,et al.In-stent restenosis.After carotid angioplasty-stenting:incidence and management.J Vasc surg,2001,33 (2):220. 被引量:1
  • 8Zhou W,Lin PH,Bush RL,et al.Management of in-sent retenosis after carotid artery stenting in high-risk patients.J Vasc surg,2006,43(2):305. 被引量:1
  • 9Setacci C,de Donato G,setacci F,et al.In-setent restenosis,after carotid andioplasty and stending:a challenge for the vasscular surgeon.Eur J Vasc Endvasc surg,2005,29(6):601. 被引量:1
  • 10Choi HM,Hbson RW,Goldstein J,et al.Technical challenges in a program of carotid artery stenting.J Vasc surg,2004,40(4):746. 被引量:1

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部